Obesity Devices: The Competitive Landscape
This article was originally published in Start Up
A look at the medtech companies that are pursuing less invasive approaches for combatting the obesity epidemic, in order of the most advanced.
You may also be interested in...
Several emerging medtechs are developing products and procedures that are less invasive, less expensive, easier to deliver, and more easily reversible than bariatric surgery. With support from investors and the FDA, these firms are poised to reap big rewards in the massive, undermet obesity market.
The latest drug development news and highlights from the Pink Sheet’s US FDA Performance Tracker.